These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3927008)

  • 1. Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscle.
    Bielefeld DR; Vary TC; Neely JR
    J Mol Cell Cardiol; 1985 Jun; 17(6):619-25. PubMed ID: 3927008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium.
    Molaparast-Saless F; Liedtke AJ; Nellis SH
    J Mol Cell Cardiol; 1987 May; 19(5):509-20. PubMed ID: 3625784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
    Lopaschuk GD; Wall SR; Olley PM; Davies NJ
    Circ Res; 1988 Dec; 63(6):1036-43. PubMed ID: 3197271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid metabolism in hearts containing elevated levels of CoA.
    Lopaschuk GD; Hansen CA; Neely JR
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H351-9. PubMed ID: 3953832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of carnitine-acyl transferase I by oxfenicine studied in vivo with [11C]-labeled fatty acids.
    Angsten G; Valind S; Takalo R; Neu H; Meurling S; Långström B
    Nucl Med Biol; 2005 Jul; 32(5):495-503. PubMed ID: 15982580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet.
    Okere IC; Chandler MP; McElfresh TA; Rennison JH; Kung TA; Hoit BD; Ernsberger P; Young ME; Stanley WC
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):113-9. PubMed ID: 17201745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart.
    Broderick TL; Quinney HA; Lopaschuk GD
    J Biol Chem; 1992 Feb; 267(6):3758-63. PubMed ID: 1740427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts.
    Madden MC; Wołkowicz PE; Pohost GM; McMillin JB; Pike MM
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2505-12. PubMed ID: 7611501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of long-chain acyl-COA metabolism.
    Tol VA
    Mol Cell Biochem; 1975 Apr; 7(1):19-31. PubMed ID: 1134497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of (+)-octanoylcarnitine in intact myocardium.
    DeMaison L; Cohen LM; Liedtke AJ; Nellis SH; Whitesell LF; Eggleston A
    Basic Res Cardiol; 1988; 83(1):77-86. PubMed ID: 3377743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
    Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
    Alam N; Saggerson ED
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine.
    Stephens TW; Higgins AJ; Cook GA; Harris RA
    Biochem J; 1985 Apr; 227(2):651-60. PubMed ID: 4004784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitate oxidation by the mitochondria from volume-overloaded rat hearts.
    Christian B; El Alaoui-Talibi Z; Moravec M; Moravec J
    Mol Cell Biochem; 1998 Mar; 180(1-2):117-28. PubMed ID: 9546638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DL-2-bromopalmitoyl-CoA and bromoacetyl-CoA in rat liver and heart mitochondria. Inhibition of carnitine palmitoyltransferase and displacement of [14C]malonyl-CoA from mitochondrial binding sites.
    Edwards MR; Bird MI; Saggerson ED
    Biochem J; 1985 Aug; 230(1):169-79. PubMed ID: 4052034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat.
    McGarry JD; Mills SE; Long CS; Foster DW
    Biochem J; 1983 Jul; 214(1):21-8. PubMed ID: 6615466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats.
    Lopaschuk GD; Spafford M
    Circ Res; 1989 Aug; 65(2):378-87. PubMed ID: 2526694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.
    Saddik M; Gamble J; Witters LA; Lopaschuk GD
    J Biol Chem; 1993 Dec; 268(34):25836-45. PubMed ID: 7902355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
    Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
    J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
    Brady PS; Brady LJ
    Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.